Patents by Inventor Anders DAMHOLT

Anders DAMHOLT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Probiotic strain and compositions comprising said strain
    Patent number: 11653689
    Abstract: The present invention relates to Bifidobacterium breve deposited as DSM 32356 and compositions comprising said strain. The composition may further comprise at least one other bacterial strain and/or at least one compound which may be an NSAID such as acetylsalicylic acid (aspirin). In a presently preferred embodiment the invention relates to Bifidobacterium breve deposited as DSM 32356 for use in the support of the defense against intestinal tissue damage such as intestinal mucosal breaks or lesions e.g. in connection with NSAID administration such as in connection with administration of acetylsalicylic acid (aspirin). The invention further provides a method of supporting the defense against intestinal tissue damage, the method comprising administering the Bifidobacterium breve strain deposited as DSM 32356 to a subject in need thereof, e.g. to a subject in need of NSAID treatment.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: May 23, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Brynjulf Mortensen, Anders Damholt, Anja Wellejus, Vibeke Westphal Stennicke, Johan E. T. Van Hycklama Vlieg
  • PROBIOTIC BIFIDOBACTERIUM BREVE STRAIN AND COMPOSITIONS COMPRISING SAID STRAIN
    Publication number: 20210153535
    Abstract: The present invention relates to Bifidobacterium breve deposited as DSM 32356 and compositions comprising said strain. The composition may further comprise at least one other bacterial strain and/or at least one compound which may be an NSAID such as acetylsalicylic acid (aspirin). In a presently preferred embodiment the invention relates to Bifidobacterium breve deposited as DSM 32356 for use in the support of the defense against intestinal tissue damage such as intestinal mucosal breaks or lesions e.g. in connection with NSAID administration such as in connection with administration of acetylsalicylic acid (aspirin). The invention further provides a method of supporting the defense against intestinal tissue damage, the method comprising administering the Bifidobacterium breve strain deposited as DSM 32356 to a subject in need thereof, e.g. to a subject in need of NSAID treatment.
    Type: Application
    Filed: May 1, 2019
    Publication date: May 27, 2021
    Applicant: Chr. Hansen A/S
    Inventors: Brynjulf MORTENSEN, Anders DAMHOLT, Anja WELLEJUS, Vibeke WESTPHAL STENNICKE, Johan E. T. VAN HYCKLAMA VLIEG